keyword
https://read.qxmd.com/read/38497569/the-role-of-surgery-and-deescalation-for-hpv-related-oropharyngeal-cancer
#21
JOURNAL ARTICLE
Kevin J Contrera, Mihir R Patel, Barbara Burtness, Ranee Mehra, Robert L Ferris
Recently published and ongoing trials are helping to define the role of transoral robotic surgery for oropharyngeal cancer. Evidence to date supports the use of surgery as a valuable tool in the multidisciplinary deescalation of low-risk human papillomavirus-related oropharyngeal squamous cell carcinoma.
March 18, 2024: Cancer
https://read.qxmd.com/read/38490491/proposals-for-the-delineation-of-neck-clinical-target-volume-for-definitive-radiation-therapy-in-patients-with-oral-oropharyngeal-squamous-cell-cancer-based-on-lymph-node-distribution
#22
JOURNAL ARTICLE
Yun-Chang Liu, Xin Zhang, Hao-Nan Yang, Lu Zhang, Dan Li, Meng-Qi Yang, Nuo-Han Wang, Yong-Zhong Wu, Jiang-Dong Sui, Ying Wang
PURPOSE/OBJECTIVE(S): To establish the distribution pattern of cervical lymph node metastasis (LNM) and propose optimized clinical target volume (CTV) boundaries specific to oral/ oropharyngeal squamous cell cancer (OSCC/OPSCC). MATERIALS/METHODS: 531 patients with pathologically confirmed OSCC/OPSCC were enrolled from January 2013 to June 2022. Patients were stratified into two groups based on the minimal distance from the lesion's edge to the body's midline: ≤1 cm or > 1 cm...
March 13, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38481587/chordoma-of-the-oropharynx
#23
Almedina Ramas, Merima Kasumovic, Sabrina Uscupsic, Majda Mujic, Lejla Tokic
BACKGROUND: Chordoma is a rare malignant neoplasm that predominantly arises from the axial skeleton, but can also develop in unusual locations. However, there are also rare cases of "NOS" chordoma involving the oropharyx and epithelial-myoepithelial carcinoma of the parotid gland in the same patient. According to contemporary research, chordoma is a rare malignant neoplasm that arises from the embryonic remnants of the notochord. and typically involves the clivus, sacrococcygeal bones or vertebrae...
2024: Medical Archives
https://read.qxmd.com/read/38453056/in-silico-evaluation-and-feasibility-of-near-margin-less-head-and-neck-daily-adaptive-radiotherapy
#24
JOURNAL ARTICLE
Michael Dohopolski, Justin Visak, Byongsu Choi, Boyu Meng, David Parsons, Xinran Zhong, Enobong Inam, Vlad Avkshtol, Dominic Moon, David Sher, Mu-Han Lin
OBJECTIVE: We explore the potential dosimetric benefits of reducing treatment volumes through daily adaptive radiation therapy for head and neck cancer (HNC) patients using the Ethos system/Intelligent Optimizer Engine (IOE). We hypothesize reducing treatment volumes afforded by daily adaption will significantly reduce the dose to adjacent organs at risk. We also explore the capability of the Ethos IOE to accommodate this highly conformal approach in HNC radiation therapy. METHODS: Ten HNC patients from a phase II trial were chosen, and their cone-beam CT (CBCT) scans were uploaded to the adaptive RT (ART) emulator...
March 5, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38440565/understanding-correlation-of-polysomnography-parameters-with-drug-induced-sleep-endoscopy-in-obstructive-sleep-apnea
#25
JOURNAL ARTICLE
Sampurna Ghosh, Srinivas Kishore
The aim of this study was to analyze drug-induced sleep endoscopy (DISE) findings performed in 64 patients and to evaluate the association of DISE findings with PSG parameters. This retrospective, single center, observational study included patients with obstructive sleep apnoea (OSA) who have undergone DISE as part of surgical planning. DISE was performed using dexmedetomidine infusion. The data were documented as per VOTE (velum, oropharynx, tongue base and epiglottis) classification. The patient characteristics and level 2 Polysomnography (PSG) findings were analyzed with DISE findings...
February 2024: Indian Journal of Otolaryngology and Head and Neck Surgery
https://read.qxmd.com/read/38440557/epidemiological-and-histopathological-analysis-of-head-and-neck-cancers-in-northern-india-a-retrospective-review
#26
JOURNAL ARTICLE
Kamal Kishor Lakhera, Vimal Kumar, Pranav Mohan Singhal, Pinakin Patel, Aishwarya Chatterjee, Suresh Singh, Agil Babu, Raj Govind Sharma
INTRODUCTION: Head and neck malignancies are responsible for 30% of all cancers in India with a dramatic increase in numbers due to widespread tobacco consumption. This study aims to assess the epidemiological and histopathological spectrum of these tumors. MATERIALS AND METHODS: A large retrospective review of 5469 biopsy-proven patients presenting between 2018 and 2022 with head and neck cancers was done. Tumors were analysed for distribution according to sites of presentations, gender, age and histopathological profiles...
February 2024: Indian Journal of Otolaryngology and Head and Neck Surgery
https://read.qxmd.com/read/38440494/successful-treatment-of-extraosseous-plasmacytoma-of-the-oropharynx-with-cervical-lymph-node-involvement
#27
JOURNAL ARTICLE
Nurul Amilin Jaafar, Faezahtul Arbaeyah Hussain, Norhafiza Mat Lazim
Extraosseous plasmacytoma, a rare plasma cell neoplasm, was observed in a 52-year-old male with uncommon presentation in the oropharynx with cervical lymph node involvement. The patient presented with dysphonia and left neck swelling. This case report primarily focuses on the management, resulting in a successful treatment through radiotherapy.
February 2024: Indian Journal of Otolaryngology and Head and Neck Surgery
https://read.qxmd.com/read/38423050/surrogate-endpoints-in-clinical-trials-of-p16-positive-squamous-cell-carcinoma-of-the-oropharynx-an-individual-patient-data-meta-analysis
#28
JOURNAL ARTICLE
Laila A Gharzai, Emily Morris, Krithika Suresh, Phuc Felix Nguyen-Tân, David I Rosenthal, Maura L Gillison, Paul M Harari, Adam S Garden, Shlomo Koyfman, Jimmy J Caudell, Christopher U Jones, Darrion L Mitchell, Greg Krempl, John A Ridge, Michael F Gensheimer, James A Bonner, Edith Filion, Neal E Dunlap, William A Stokes, Quynh-Thu Le, Pedro Torres-Saavedra, Michelle Mierzwa, Matthew J Schipper
BACKGROUND: The increased incidence of human papillomavirus (HPV)-related cancers has motivated efforts to optimise treatment for these patients with excellent prognosis. Validation of surrogates for overall survival could expedite the investigation of new therapies. We sought to evaluate candidate intermediate clinical endpoints in trials assessing definitive treatment of p16-positive oropharyngeal cancer with chemotherapy or radiotherapy. METHODS: We did a retrospective review of five multicentre, randomised trials (NRG/RTOG 9003, 0129, 0234, 0522, and 1016) that tested radiotherapy with or without chemotherapy in patients (aged ≥18 years) with p16-positive localised head or neck squamous-cell carcinomas...
March 2024: Lancet Oncology
https://read.qxmd.com/read/38415519/comment-on-prospective-study-to-compare-efficacy-of-conventional-chemoradiotherapy-with-hypofractionated-chemoradiotherapy-in-locally-advanced-carcinoma-of-oropharynx
#29
JOURNAL ARTICLE
Erkan Topkan, Efsun Somay, Ugur Selek
No abstract text is available yet for this article.
February 1, 2024: Asian Pacific Journal of Cancer Prevention: APJCP
https://read.qxmd.com/read/38398100/polygenic-risk-score-in-predicting-esophageal-oropharyngeal-and-hypopharynx-cancer-risk-among-taiwanese-population
#30
JOURNAL ARTICLE
Yu-Che Huang, Ming-Ching Lee, Sheng-Yang Huang, Chia-Man Chou, Hui-Wen Yang, I-Chieh Chen
Esophageal cancer shares strong associations with oropharyngeal and hypopharyngeal cancers, primarily due to shared risk factors like excessive tobacco and alcohol use. This retrospective study at Taichung Veterans General Hospital involved 54,692 participants, including 385 with squamous cell carcinoma (SCC) of the esophagus, oropharynx, or hypopharynx. Using a polygenic risk score (PRS) derived from 8353 single-nucleotide polymorphisms, researchers aimed to assess its correlation with cancer incidence and prognosis...
February 7, 2024: Cancers
https://read.qxmd.com/read/38390265/real-world-use-of-first-line-pembrolizumab-platinum-taxane-combination-regimens-in-recurrent-metastatic-head-and-neck-squamous-cell-carcinoma
#31
JOURNAL ARTICLE
Christopher M Black, Dandan Zheng, Gleicy M Hair, Lei Ai, Liya Wang, Daisuke Goto, Nati Lerman, Behzad Bidadi, Glenn J Hanna
INTRODUCTION: The programmed death-1 (PD-1) immune checkpoint inhibitor pembrolizumab is currently approved in the US for the first-line (1L) treatment of recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), either alone or in combination with platinum and 5-fluorouracil (5-FU). However, the toxicity of 5-FU has motivated the study of alternate combinations that replace 5-FU with a taxane. The objective of the current study was to describe the baseline characteristics, treatment patterns and sequences, and real-world outcomes of individuals receiving pembrolizumab + platinum + taxane as 1L treatment for R/M HNSCC in the US...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38365701/the-association-of-hbv-infection-and-head-and-neck-cancer-a-systematic-review-and-meta-analysis
#32
JOURNAL ARTICLE
Rukeng Tan, Xinyu Zhu, Yutong Sun, Shihao Yang, Chao Peng, Xinkai Feng, Zengyu Chen, Yiliyaer Yimamu, Guiqing Liao, Le Yang
BACKGROUND: Hepatitis B virus (HBV) infections is an important public health problem worldwide and closely affect extrahepatic cancer. Several recent studies have investigated the relationship between HBV infection and head and neck cancer (HNC), but their findings were inconsistent.In order to address the limitations of small sample sizes, we conducted a meta-analysis to assess the association between HBV and HNC. METHODS: We systematically searched PubMed, Web of Science, Embase, Scopus, Cochrane Library, and China National Knowledge Infrastructure from inception to August 2023...
February 16, 2024: BMC Cancer
https://read.qxmd.com/read/38359743/oral-and-oropharyngeal-mucosal-lesions-clinical-epidemiological-study-of-patients-attended-at-a-reference-center-for-infectious-diseases
#33
JOURNAL ARTICLE
Clarissa Souza Mota Reis, João Gustavo Corrêa Reis, Fátima Conceição-Silva, Cláudia Maria Valete
OBJECTIVE: To determine the prevalence, epidemiological profile, and clinical characteristics of Oral or Oropharyngeal Mucosal Lesions (OOPML) in patients attended at the Otorhinolaryngology Service of the Evandro Chagas National Institute of Infectious Diseases (INI-FIOCRUZ) from 2005 to 2017. METHODS: Statistical analysis of descriptive data from medical records (gender, age, education level, skin color, origin, smoking, alcoholism, HIV co-infection, time of disease evolution, first symptom, and OOPML location) was performed...
February 1, 2024: Brazilian Journal of Otorhinolaryngology
https://read.qxmd.com/read/38358211/extranodal-natural-killer-t-cell-lymphoma-nasal-type-simulating-osteoradionecrosis-with-metachronic-b-lymphoma-in-the-pelvis-case-report
#34
Frida S Colín-Guadarrama, Violeta E Flores-Solano, Argelia Berenice-Rodríguez, Víctor H Toral-Rizo
Extranodal Natural Killer/T Cell Lymphoma Nasal Type (EN-NK/T-CL-NT) is a non-Hodgkin extranodal lymphoma of unfavorable prognosis due to its aggressive nature. This neoplasm mainly affects the paranasal sinuses, nasopharynx, oropharynx, oral cavity, palate, and rarely intestinal, gastric and skin regions. 50-year-old female with a history of lymphoma in nasal and pelvic region. At four years of tumors-free, has facial asymmetry, accompanied by sub-palpebral, nasal and lip edema. Intraoral examination revealed a large ulceration suggestive of osteoradionecrosis...
2024: Indian Journal of Pathology & Microbiology
https://read.qxmd.com/read/38341096/tumor-volume-and-cancer-stem-cell-expression-as-prognostic-markers-for-high-dose-loco-regional-failure-in-head-and-neck-squamous-cell-carcinoma-a-dahanca-19-study
#35
JOURNAL ARTICLE
Morten Horsholt Kristensen, Mia Kristina Sørensen, Trine Tramm, Jan Alsner, Brita Singers Sørensen, Christian Maare, Jørgen Johansen, Hanne Primdahl, Åse Bratland, Claus Andrup Kristensen, Maria Andersen, Jacob Kinggaard Lilja-Fischer, Anne Ivalu Sander Holm, Eva Samsøe, Christian Rønn Hansen, Ruta Zukauskaite, Jens Overgaard, Jesper Grau Eriksen
BACKGROUND AND PURPOSE: Reliable and accessible biomarkers for patients with Head and Neck Squamous Cell Carcinoma (HNSCC) are warranted for biologically driven radiotherapy (RT). This study aimed to investigate the prognostic value of putative cancer stem cell (CSC) markers, hypoxia, and tumor volume using loco-regional high-dose failure (HDF) as endpoint. MATERIALS AND METHODS: Tumor tissue was retrieved from patients treated with primary chemo-(C-)RT and nimorazole for HNSCC in the Danish Head and Neck Cancer Study Group (DAHANCA) 19 study...
February 9, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38339366/risk-prediction-models-for-oral-cancer-a-systematic-review
#36
REVIEW
Aufia Espressivo, Z Sienna Pan, Juliet A Usher-Smith, Hannah Harrison
In the last 30 years, there has been an increasing incidence of oral cancer worldwide. Earlier detection of oral cancer has been shown to improve survival rates. However, given the relatively low prevalence of this disease, population-wide screening is likely to be inefficient. Risk prediction models could be used to target screening to those at highest risk or to select individuals for preventative interventions. This review (a) systematically identified published models that predict the development of oral cancer and are suitable for use in the general population and (b) described and compared the identified models, focusing on their development, including risk factors, performance and applicability to risk-stratified screening...
January 31, 2024: Cancers
https://read.qxmd.com/read/38292333/radiotherapy-induces-an-increase-in-serum-antioxidant-capacity-reflecting-tumor-response
#37
JOURNAL ARTICLE
F V Naumann, J H A M Kaanders, W J M Peeters, G J Adema, F C G J Sweep, J Bussink, P N Span
BACKGROUND AND PURPOSE: Radiotherapy (RT) is a mainstay component of treatment for patients with head and neck squamous cell carcinoma (HNSCC), but responses vary. As RT relies upon oxidative damage, antioxidant expression in response to RT-induced reactive oxygen species (ROS) could compromise treatment response. We aimed to examine local and systemic antioxidant responses to increased RT-induced ROS in relation to treatment success. MATERIALS AND METHODS: Nuclear factor erythroid 2-related factor 2 (NRF2), the main antioxidant transcription factor, was immunofluorescently stained in FaDu cells and in tumor biopsies of patients with oral cavity/oropharynx HNSCC before and after five fractions of RT...
March 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38260220/in-silico-analysis-of-adjuvant-head-and-neck-online-adaptive-radiation-therapy
#38
JOURNAL ARTICLE
Sean All, Xinran Zhong, Byongsu Choi, Jin Sung Kim, Tingliang Zhuang, Vladimir Avkshtol, David Sher, Mu-Han Lin, Dominic H Moon
PURPOSE: Recently developed online adaptive radiation therapy (OnART) systems enable frequent treatment plan adaptation, but data supporting a dosimetric benefit in postoperative head and neck radiation therapy (RT) are sparse. We performed an in silico dosimetric study to assess the potential benefits of a single versus weekly OnART in the treatment of patients with head and neck squamous cell carcinoma in the adjuvant setting. METHODS AND MATERIALS: Twelve patients receiving conventionally fractionated RT over 6 weeks and 12 patients receiving hypofractionated RT over 3 weeks on a clinical trial were analyzed...
January 2024: Advances in Radiation Oncology
https://read.qxmd.com/read/38256641/the-value-of-the-endoscope-holding-arm-in-transoral-pharyngeal-surgery
#39
JOURNAL ARTICLE
Aris I Giotakis, Evangelos I Giotakis, Efthymios Kyrodimos
BACKGROUND: Transoral pharyngeal surgery is mainly feasible with the use of a microscope or robotic systems. Data about alternative methods, with lower costs and easier availability, are sparse. We intended to examine to what extent the endoscope-holding arm is a suitable alternative to the microscope or robotic systems. MATERIAL AND METHODS: We retrospectively reviewed subjects who underwent pharyngeal tumor resection with the endoscope-holding arm in our university department...
January 16, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38242007/tissue-contexture-determines-the-pattern-and-density-of-tumor-infiltrating-immune-cells-in-hpv-associated-squamous-cell-carcinomas-of-oropharynx-and-uterine-cervix
#40
JOURNAL ARTICLE
Lucie Pavelková, Eliška Táborská, Linn A Syding, Klára Plačková, Ekaterina Simonova, Kamila Hladíková, Michal Hensler, Jan Laco, Vladimír Koucký, Michal Zábrodský, Jan Bouček, Marek Grega, Kateřina Rozkošová, Hana Vošmiková, Michael J Halaška, Lukáš Rob, Ivan Práznovec, Miroslav Hodek, Milan Vošmik, Petr Čelakovský, Viktor Chrobok, Aleš Ryška, Lenka Palová-Jelínková, Radek Špíšek, Anna Fialová
The profile of the antitumor immune response is an important factor determining patient clinical outcome. However, the influence of the tissue contexture on the composition of the tumor microenvironments of virally induced tumors is not clearly understood. Therefore, we analyzed the immune landscape of two HPV-associated malignancies: oropharyngeal squamous cell carcinoma (OPSCC) and squamous cell carcinoma of uterine cervix (CESC). We employed multiplex immunohistochemistry and immunofluorescence to evaluate the density and spatial distribution of immune cells in retrospective cohorts of OPSCC and CESC patients...
January 18, 2024: Translational Oncology
keyword
keyword
55849
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.